person
as of 2026-07-01Bjørn H Ebdrup, MD, PhD
at a glance
Roles: Principal Investigator, Author, Investigator+Author
KOL signal score 13
5 publications · 1 high-value
Cross-drug reach: 1 competitor drugs
Synthesized from structured facts only — each point cited above.
Profile
Affiliation
University of Copenhagen
Roles
Principal Investigator, Author, Investigator+Author
KOL signal
13
Publications
5 (1 high-value)
Trial investigator
yes
Publishes on
1 drugs
Trials led
1
The Sub-Sero Study
NCT03994965Phase 2Withdrawn
Publications & congress
5
High-Dose Vitamin D3 Supplementation During Pregnancy and Test-Based Cognitive Performance at Age 10 Years: A Post Hoc Secondary Analysis of a Randomized Clinical Trial.
JAMA network open · 2026 · high-value
Exploring brain structural effects of dopaminergic antagonism and partial agonism in antipsychotic-naïve patients with first-episode psychosis using normative modeling.
Psychiatry and clinical neurosciences · 2026
Confirmatory factor analysis of competing PANSS negative symptom models: data from OPTiMiSE first-episode schizophrenia study.
BJPsych open · 2025
Using computer vision of facial expressions to assess symptom domains and treatment response in antipsychotic-naïve patients with first-episode psychosis.
Acta psychiatrica Scandinavica · 2025
Functional Connectivity Between Auditory and Medial Temporal Lobe Networks in Antipsychotic-Naïve Patients With First-Episode Schizophrenia Predicts the Effects of Dopamine Antagonism on Auditory Verbal Hallucinations.
Biological psychiatry global open science · 2024
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
publishes on
drug
PRINCIPAL_INVESTIGATOR
trial